ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,000 | +54.2% | 10,813 | +49.5% | 0.00% | – |
Q2 2023 | $144,000 | -92.0% | 7,234 | -93.1% | 0.00% | – |
Q1 2023 | $1,795,000 | +784.2% | 104,765 | +909.0% | 0.00% | – |
Q4 2022 | $203,000 | +2155.6% | 10,383 | +1848.0% | 0.00% | – |
Q3 2022 | $9,000 | -96.5% | 533 | -97.2% | 0.00% | – |
Q2 2022 | $259,000 | +547.5% | 18,829 | +643.3% | 0.00% | – |
Q1 2022 | $40,000 | -79.5% | 2,533 | -71.7% | 0.00% | – |
Q4 2021 | $195,000 | +91.2% | 8,941 | +162.3% | 0.00% | – |
Q3 2021 | $102,000 | -15.0% | 3,409 | +25.3% | 0.00% | – |
Q2 2021 | $120,000 | -92.5% | 2,720 | -92.4% | 0.00% | – |
Q1 2021 | $1,592,000 | +19800.0% | 35,886 | +26286.8% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 136 | -9.3% | 0.00% | – |
Q1 2020 | $2,000 | -92.3% | 150 | -86.7% | 0.00% | – |
Q4 2019 | $26,000 | +62.5% | 1,124 | +77.0% | 0.00% | – |
Q3 2018 | $16,000 | -52.9% | 635 | -63.5% | 0.00% | – |
Q2 2018 | $34,000 | -24.4% | 1,741 | -27.3% | 0.00% | – |
Q1 2018 | $45,000 | – | 2,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |